Back
Mineralys Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
MLYS
Mineralys Therapeutics, Inc.
Last Price:
$27.01
Seasonality Move:
1.47%
7 Day Trial
ALL ACCESS PASS
$
7
Mineralys Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Mineralys Therapeutics, Inc. has on average historically risen by 27.8% based on the past 3 years of stock performance.
-
Mineralys Therapeutics, Inc. has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Mineralys Therapeutics, Inc. Stock Undervalued?The current Mineralys Therapeutics, Inc. [MLYS] share price is $26.97. The Score for MLYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MLYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Mineralys Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Mineralys Therapeutics, Inc. has on average historically risen by 27.8% based on the past 3 years of stock performance.
Mineralys Therapeutics, Inc. Stock Rating
Sell
38
Mineralys Therapeutics, Inc. (MLYS)
is a Sell
Is Mineralys Therapeutics, Inc. overpriced?
-
Mineralys Therapeutics, Inc. has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Mineralys Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mineralystx.com
52-Week Data
52-Week High:
47.65
52-Week Low:
10.44
Prediction Charts
Market Cap:
2.3B
Price in USD:
26.97
Volume:
1.6M
Beta:
0.68
Technical Analysis
SMA50:
28.13
SMA100:
33.11
SMA200:
29.59
52-Wk Change:
92.64%
Stock Predictions
-
Is Mineralys Therapeutics, Inc. stock public?Yes, Mineralys Therapeutics, Inc. is a publicly traded company.
-
What is the Mineralys Therapeutics, Inc. stock quote today?The Mineralys Therapeutics, Inc. stock price is 26.97 USD today.
-
How to buy Mineralys Therapeutics, Inc. stock online?You can buy Mineralys Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 26.28 | 25.73 | 26.98 | 25.44 |
| Mar-17 | 25.65 | 25.02 | 25.86 | 24.90 |
| Mar-18 | 24.53 | 23.90 | 24.63 | 23.60 |
| Mar-19 | 23.69 | 23.28 | 24.11 | 23.08 |
| Mar-20 | 23.12 | 24.07 | 24.42 | 22.64 |
| Mar-23 | 24.08 | 23.65 | 24.50 | 23.21 |
| Mar-24 | 23.27 | 22.88 | 23.87 | 22.42 |
| Mar-25 | 23.62 | 24.62 | 24.64 | 23.59 |
| Mar-26 | 24.00 | 23.61 | 24.51 | 23.52 |
| Mar-27 | 23.42 | 23.68 | 24.22 | 23.30 |
| Mar-30 | 23.79 | 23.51 | 24.56 | 23.40 |
| Mar-31 | 24.27 | 27.09 | 27.56 | 24.07 |
| Apr-1 | 28.01 | 26.41 | 29.10 | 26.27 |
| Apr-2 | 25.49 | 26.97 | 27.03 | 25.49 |
Mineralys Therapeutics, Inc. Earnings
Mineralys Therapeutics, Inc. Earnings Report: Per Share Mineralys Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Mineralys Therapeutics, Inc. Forecast Revenue Growth
Mineralys Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Mineralys Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.27 per share.
* Mineralys Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.